Francesco Costacurta
Innsbruck Medical University(AT)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Computational Drug Discovery Methods, vaccines and immunoinformatics approaches, Virus-based gene therapy research, Mosquito-borne diseases and control
Most-Cited Works
- → Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors(2023)166 cited
- → SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376(2022)132 cited
- → A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition(2022)31 cited
- → Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir(2024)15 cited
- → SARS-CoV-2 3CLpro mutations confer resistance to Paxlovid (nirmatrelvir/ritonavir) in a VSV-based, non-gain-of-function system(2022)14 cited
- → A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system(2024)10 cited
- → A comprehensive study of SARS-CoV-2 main protease (M pro ) inhibitor-resistant mutants selected in a VSV-based system(2023)9 cited
- → Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system(2024)9 cited
- → Identification of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir(2023)2 cited